| Kawasaki disease: basic and pathological findings. | |
| | |
MedLine Citation:
|
PMID: 23188196 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Kawasaki disease (KD) is considered to be a kind of systemic vasculitis syndrome. It most frequently affects infants and young children and primarily invades medium-sized muscular arteries, including the coronary arteries. The etiology of KD is unknown, but epidemiological data suggest involvement of infectious agents, such as bacteria and viruses, in the onset of KD. In addition, host genetics underlie the disease's pathogenesis. Histologically, coronary arteritis begins 6-8 days after KD onset, and inflammation of all layers of the artery rapidly ensues. The inflammation spreads completely around the artery, resulting in severe damage to structural components. Then, the artery begins to dilate. KD arteritis is characterized by inflammation consisting of marked accumulation of monocytes/macrophages. Aberrant activation of monocytes/macrophages is thought to be involved in the formation of vascular lesions. Inflammatory-cell infiltration persists until about the 25th day of the disease, after which the inflammatory cells gradually decrease in number. Lesions in all arteries are relatively synchronous, as they evolve from acute to chronic injury. If a giant aneurysm remains or vessel recanalization occurs after thrombotic occlusion of an aneurysm, remodeling of the vascular structure, sometimes including even reocclusion, continues even in the remote stage. |
| | |
Authors:
|
Kei Takahashi; Toshiaki Oharaseki; Yuki Yokouchi; Shiro Naoe; Tsutomu Saji |
Related Documents
:
|
23232306 - Small incision fasciotomy in a patient with compartment syndrome and peripheral arteria... 23661676 - Basilar artery diameter is an independent predictor of incident cardiovascular events. 23218196 - Pulmonary vein thrombosis associated with a large hiatal hernia. 23415176 - Takayasu arteritis revisited: current diagnosis and treatment. 20174336 - Patents. 15037276 - Perivascular application of c-type natriuretic peptide attenuates neointimal hyperplasi... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-11-28 |
Journal Detail:
|
Title: Clinical and experimental nephrology Volume: - ISSN: 1437-7799 ISO Abbreviation: Clin. Exp. Nephrol. Publication Date: 2012 Nov |
Date Detail:
|
Created Date: 2012-11-28 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9709923 Medline TA: Clin Exp Nephrol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Pathology, Toho University Ohashi Medical Center, 2-17-6 Ohashi, Meguro, Tokyo, 153-8515, Japan, keitak@oha.toho-u.ac.jp. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Limited pulmonary MPA, a new MPA entity? A rheumatologist's perspective.
Next Document: Skin involvement in ANCA-associated vasculitis.